← Open Payments lookup

DANIELLE MCFADDEN: Open Payments

NPI 1215607122 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,144 in 100 payments from 16 companies in 2025. Trend: 2023 $1,541 · 2024 $1,886 · 2025 $2,144

Food & beverage: $2,049Education: $95
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP22$457
GlaxoSmithKline, LLC.24$408
Viatris Specialty LLC11$312
Regeneron Healthcare Solutions, Inc.10$276
GENZYME CORPORATION9$158
Insmed, Inc.7$118
United Therapeutics Corporation4$88
Verona Pharma, Inc.2$68
Grifols USA, LLC2$49
Takeda Pharmaceuticals U.S.A., Inc.2$48

Products named: DUPIXENT, TRELEGY ELLIPTA, YUPELRI, FASENRA, BREZTRI, Arikayce, NUCALA, Tyvaso.

Industry payments across IN — which companies pay providers there.